Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies by Yusuke Inoue, MD, PhD, Yoshihiro Kitahara, MD, Masato Karayama, MD, PhD, Kazuhiro Asada, MD, PhD, Koji Nishimoto, MD, PhD, Shun Matsuura, MD, PhD, Dai Hashimoto, MD, PhD, Masato Fujii, MD, PhD, Takashi Matsui, MD, PhD, Nao Inami, MD, Mikio Toyoshima, MD, PhD, Hiroyuki Matsuda, MD, PhD, Masaki Ikeda, MD, PhD, Mitsuru Niwa, MD, PhD, Yusuke Kaida, MD, PhD, Masaki Sato, MD, PhD, Yasuhiro Ito, MD, Hideki Yasui, MD, PhD, Yuzo Suzuki, MD, PhD, Hironao Hozumi, MD, PhD, Kazuki Furuhashi, MD, PhD, Noriyuki Enomoto, MD, PhD, Tomoyuki Fujisawa, MD, PhD, Naoki Inui, MD, PhD, Takafumi Suda, MD, PhD

Get full text